Table 4.
Hazard ratio of AKI (95% CI) during follow-up by categories of UACR and eGFR adjusted for age, gender, race, and cardiovascular risk factorsa
| eGFR (ml/min per 1.73 m2) | Albumin-to-Creatinine Ratio (mg/g) |
|||||
|---|---|---|---|---|---|---|
| <10 | 10 to 29 | 30 to 299 | ≥300 | Total | Adjusted | |
| ≥105 | 1.2 (0.7, 2.1) | 0.7 (0.2, 2.2) | 1.8 (0.7, 4.3) | 8.6 (3.3, 22.4) | 1.1 (0.7, 1.6) | 1.1 (0.7, 1.6) |
| 90 to 104 | Reference | 1.6 (0.7, 3.2) | 1.8 (0.8, 4.0) | 6.5 (2.5, 16.8) | Reference | Reference |
| 75 to 89 | 0.8 (0.5, 1.3) | 2.1 (1.1, 4.0) | 2.4 (1.1, 4.9) | 5.6 (2.0, 15.8) | 0.9 (0.7, 1.3) | 0.9 (0.7, 1.3) |
| 60 to 74 | 1.3 (0.9, 2.0) | 3.4 (2.0, 5.8) | 2.9 (1.5, 5.7) | 9.7 (4.7, 19.9) | 1.5 (1.1, 2.1) | 1.5 (1.1, 2.1) |
| 45 to 59 | 2.6 (1.5, 4.3) | 4.5 (2.2, 9.2) | 6.2 (3.4, 11.5) | 5.8 (2.0, 16.6) | 2.9 (2.0, 4.2) | 2.5 (1.7, 3.7) |
| 30 to 44 | 9.3 (4.7, 18.5) | 16.1 (5.6, 46.3) | 12.2 (5.3, 28.1) | 26.4 (13.1, 53.2) | 10.0 (6.4, 15.6) | 7.0 (4.4, 11.0) |
| 15 to 29 | 11.3 (1.5, 83.0) | – | 17.7 (2.4, 131.0) | 23.0 (10.0, 52.8) | 14.5 (7.1, 29.7) | 5.6 (2.6, 12.1) |
| Total | Reference | 1.9 (1.4, 2.6) | 2.6 (1.9, 3.5) | 8.0 (5.6, 11.6) | – | – |
| Adjusted | Reference | 1.9 (1.4, 2.6) | 2.2 (1.6, 3.0) | 4.8 (3.2, 7.2) | – | – |
a“Total” refers to adjustment by age, gender, race, and cardiovascular risk factors but not the corresponding column or row category (e.g., not eGFR category for UACR category estimates). “Adjusted” includes adjustment for age, gender, race, cardiovascular risk factors, and corresponding column or row category.